cs.LGJul 14, 2026

Generating Developable 3D Molecules via Pocket-Conditioned Diffusion and Property-Aware Optimization

Authors: Ruoxi GaoJiangweizhi PengZiqi ChenFrazier N. BakerDavid C. KomboJohn L. KaneAndrew A. ScholteYi Li+5 more

Organizations: Computer Science and Engineering, The Ohio State University, Columbus, OH 43210. · Industrial and System Engineering, University of Minnesota, Minneapolis, MN 55455. · Google Cloud, Google LLC, Mountain View, CA 94043. · Medicinal Chemistry Department, Integrated Drug Discovery, Sanofi, Cambridge, MA 02141. · In-Vitro Biology Department, Integrated Drug Discovery, Sanofi, Cambridge, MA 02141. · Electrical and Computer Engineering, University of Minnesota, Minneapolis, MN 55455. · Biomedical Informatics, The Ohio State University, Columbus, OH 43210. · Medicinal Chemistry and Pharmacognosy, The Ohio State University, Columbus, OH 43210. · Translational Data Analytics Institute, The Ohio State University, Columbus, OH 43210.

Abstract

Drug discovery and development is time-consuming and resource-intensive, motivating computational approaches such as diffusion models for de novo drug design. Many such models follow the structure-based drug design (SBDD) paradigm, generating molecules to fit a target binding pocket. However, existing diffusion-based SBDD methods typically couple pocket and ligand representation learning, model interactions only at the atom level, and prioritize binding affinity over other developability properties. Here, we introduce conDitar-dev, a conditional diffusion-based SBDD framework for generating ligands with strong binding affinities and favorable ADMET properties. It consists of three modules: msPRL, a pretrained multi-scale pocket representation learning module; conDitar, a pocket-conditioned diffusion model guided by msPRL representations; and paOPT, a generation-time method for optimizing ligand developability. On a newly curated benchmark of human disease targets, conDitar outperforms state-of-the-art SBDD baselines, achieving an average binding score of -8.85 kcal/mol. Across five ADMET properties, conDitar-dev improves performance by up to 73% over conDitar. To further validate the abilities of conDitar-dev to generate developable molecules, we have applied it to two validated druggable targets: programmed death-ligand 1 (PD-L1) and colony-stimulating factor 1 receptor (CSF1R) proteins. Top-ranked generatively designed molecules and their analogs have been experimentally synthesized and biologically tested. Two molecules generated directly by conDitar-dev for PD-L1 exhibited SPR-derived KDK_D values of 3.49 and 3.75 μμM, respectively. Hit expansion based on conDitar-dev-designed molecules identified selective CSF1R inhibitors with IC50_{50} values as low as 200 nM, while also uncovering opportunities for drug repositioning.

Explore similar work

CardsList